PaulaRaffinPohlmannMD

Clinical Trials

• HKI-272 for HER2-Positive Breast Cancer and Brain Metastases Start of enrollment: 2012 Feb 01

  Active, not recruiting

  Phase 2

• T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Start of enrollment: 2013 May 01

  Active, not recruiting

  Phase 2

• Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery Start of enrollment: 2013 Dec 13

  Active, not recruiting

  Phase 3

• Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies Start of enrollment: 2014 Mar 01

  Unknown status

  Phase 1

• Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients Start of enrollment: 2017 Jan 31

  Completed

  Phase 2

• Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer Start of enrollment: 2017 Aug 29

  Active, not recruiting

  Phase 2

• The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer Start of enrollment: 2018 Jun 21

  Active, not recruiting

  Phase 2

• Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery Start of enrollment: 2018 Oct 08

  Terminated

  Phase 2

• WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor Start of enrollment: 2019 Apr 01

  Active, not recruiting

  Phase 1

• Join now to see all